French Ministry bans Antheor vena cava filters:
This article was originally published in Clinica
Executive Summary
The French Ministry for Social Affairs has banned the sale and use of some vena cava filters manufactured by French company Antheor. Following reports of serious incidents, the authorities say the filter could migrate into the intercardiac cavities during the first few months after implantation. The ministry has called for the immediate withdrawal of Antheor D3, DC3, D4 and DC4 filters and for the precautionary removal of its Standard and Large vena cava filters.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.